Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
News
|
Comment
|
Features
|
Analysis
|
Supplements & Reports
|
People
|
Events
|
Multimedia
|
Science Abstracts
|
BREAKING NEWS
Teva triumphs with €3.6 billion bid for Ratiopharm
Today
Teva Pharmaceutical Industries has won the race to acquire Ratiopharm for €3.6 billion. The Israeli firm fought off competition from Pfizer and Actavis to buy world's six-largest generics maker in an auction that lasted nine months. More to follow…
 
Key MEP says EU patient information proposal "must go through"
17 March 2010
The MEP responsible for guiding the controversial patient information proposal through the European Parliament says he is not prepared to see it derailed by ...
AstraZeneca fluffs its lines on emerging markets
16 March 2010
AstraZeneca has hastily rewritten expectations for its business in emerging markets, an area of key growth if it is to prosper after several key products lose ...
Merck/Portola's betrixaban shows bleeding benefit in Phase IIb
16 March 2010
Merck / Portola Pharmaceuticals ' investigational Factor Xa inhibiting anticoagulant betrixaban was associated with significantly less clinically relevant ...
Emerging markets to make up 48% of pharma growth, IMS Health says
16 March 2010
IMS Health is predicting that emerging markets will expand by $90 billion during 2009-13, contributing 48% of annual pharmaceutical market growth in 2013, a ...
 
Shionogi looks to new products, in-house R&D to weather Crestor expiries
Today
Shionogi is aiming to raise its consolidated net sales to ¥375 billion ($4.1 billion) over the next five years, ahead of a challenging period after 2016 when cholesterol therapy Crestor ...
Tekmira and Pfizer sign siRNA delivery deal
Today
Tekmira Pharmaceuticals ' shares rose by 24% on news that it has agreed an RNA drug delivery deal with Pfizer . The Canadian firm's shares closed at 87 cents each on Tuesday and opened up by one ...
Hikma has $400 million to make acquisitions this year
Today
Hikma Pharmaceuticals is in a position to carry out acquisitions worth up to $400 million in total this year, CEO Said Darwazah has told Scrip. "In 2009 we were actively engaged with certain ...
Another US settlement for Takeda on Actos litigation, with Mylan
Today
Mylan has become the third company to settle outstanding litigation with Takeda Pharmaceutical regarding the antidiabetic Actos (pioglitazone), allowing it to market its generic version in the US on ...
 
US fast track for Acucela/Otsuka's dry AMD drug
Today
The US venture Acucela has received fast track status from the US FDA for its lead in-house development project, ACU-4429, which is currently in Phase II development for dry age-related macular ...
Roche files Actemra for prevention of joint damage in US
17 March 2010
Genentech ( Roche ) has submitted a supplemental BLA to the US FDA for its first-in-class interleukin-6 inhibitor Actemra (tocilizumab) for an indication of prevention of structural joint damage and ...
FDA sets panel review dates for analgesic Acurox and infantile spasms therapy Acthar
17 March 2010
The US FDA's anaesthetic and life support drugs advisory committee, in conjunction with the drug safety and risk management advisory committee, has scheduled a meeting for 22 April to review Acura ...
Bioprojet's orphan drug for EDS enters Phase III trials
16 March 2010
The privately owned French biotech firm Bioprojet says that its new compound for excessive daytime sleepiness (EDS), pitolisant, has shown good results in several European Phase II trials and has now ...
 
China spending big as health reforms gather pace
17 March 2010
China's central government spent Yuan116.2 billion ($17.1 billion) on measures to support reforms to the national pharmaceutical and healthcare system in 2009, and is gearing up for further changes ...
Denmark's antitrust authority wants more competition in pharma retail
17 March 2010
Denmark’s competition authority, Konkurrencestyrelsen, has asked the national health ministry of interior and health to change existing regulations so that it becomes easier to open new pharmacies ...
US review of countries' intellectual property policies under fire at first public hearing
17 March 2010
The United States Trade Representative 's review of its trading partners' intellectual property provisions came under fire from NGOs at the first ever 301 public hearing held recently. They argued ...
UNITAID funding could be doubled through US traveller donation initiative
17 March 2010
The international drug purchasing facility UNITAID could potentially double its budget through an innovative financing initiative based on voluntary donations from US airplane passengers. UNITAID has ...
 
PEOPLE
Timothy Barabe joins Affymetrix Timothy Barabe has been appointed executive vice-president and chief financial officer at ...
New COO at Endo Pharmaceuticals Endo Pharmaceuticals (US) has named Julie McHugh chief operating officer. Most recently, Ms McHugh ...
New appointment at Forbion Capital Partners Forbion Capital Partners has opened a new office in Munich, Germany, and has appointed Dr Holger ...
>> More People News...

EXPERT VIEW
Patient information – what price public trust?
17 March 2010
Ian Schofield
Trust and respect seem to be in short supply these days, at least where certain sectors of society ...

Market Insight: Big pharma hit by Greece's fiscal crisis
09 March 2010

Hospitals' failure to pay pharmaceutical companies and newly announced price cuts are just some of ...

 Market Insight - Fear gives way to prudence a...

How to run clinical trials in the Middle East - why the GCC?
04 March 2010

A grouping of Middle Eastern countries came together under the auspices of the Gulf Co-operation ...

How to run clinical trials in the Middle East - Jordan
04 March 2010

Jordan has a population of 6.35 million and its GDP per capita is $5,000, while its healthcare ...

MULTIMEDIA
Scrip in a minute - week ending March 12th 12 March 2010

Get the Flash Player to see this player.

Private investment round-up: February 2010
15 March 2010
Simon Varcoe
Just as it appeared that the private investment market was beginning to rebound after last year's ...

European Medicines Agency and logos: snakes, DNA and the pestle and mortar
22 December 2009
Elizabeth Sukkar
Logos are said to be an important part of an organisation's branding. Really good logos contribute ...

Face to Face with Sandoz's "growth guy" Jeff George
04 March 2010
Eleanor Malone
Jeff George took over as head of Sandoz, Novartis's generics business, in late 2008. With a big ...

CPhI Worldwide 2009
13 October 2009
Scrip's official preview of CPhI Worldwide, ICSE, P-MEC and BioPh 2009

Scrip's Stock Tracker February 2010
12 March 2010
Ashley Yeo
Talk of dividends being under threat at companies such as Bristol-Myers Squibb , Pfizer and Lilly , ...

EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm